臨床および実験神経免疫学ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Multiple Sclerosis's Neuropsychiatric Manifestations and Mental Health Symptoms Linked to it

Adelino Canario

Multiple sclerosis is the most common chronic neurologic condition affecting young adults in the United States, with a prevalence of approximately 1 in 1000. Previously thought to be an inflammatory, demyelinating disease primarily affecting central nervous system (CNS) white matter, more recent imaging studies have shown that significant damage to cortical gray matter also occurs. Multiple sclerosis affects twice as many women as men, and the prevalence rises as geographical distance from the equator increases. Visual disturbances (diplopia, blurred vision), weakness, gait disturbance, vertigo, fatigue, urinary retention and incontinence, and difficulties with speech and swallowing are all common clinical signs and symptoms of MS. Neuropsychiatric symptoms are also common and may be the first sign of MS. Because many of the typical signs and symptoms are nonspecific and pseudoneurologic, patients are frequently mistaken for having a primarily mental illness, and a diagnosis may be delayed [1]